CUE vs MAR · rev $9.3M vs P/E 32, rev $26.19B
Cue Biopharma (CUE) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
CUE currently screens at market cap $59.5M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the CUE and MAR stock pages for the full models.
Not investment advice.